Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2000 1
2014 2
2015 1
2016 2
2018 1
2019 1
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Dolutegravir: an exciting new kid on the block.
Blanco Arévalo JL, Whitlock GG. Blanco Arévalo JL, et al. Expert Opin Pharmacother. 2014 Mar;15(4):573-82. doi: 10.1517/14656566.2014.868883. Epub 2014 Jan 22. Expert Opin Pharmacother. 2014. PMID: 24446762 Review.
Sexually Transmitted Infections: Experience in a Multidisciplinary Clinic in a Tertiary Hospital (2010-2013).
Moreno-Ribera N, Fuertes-de Vega I, Blanco-Arévalo JL, Bosch-Mestres J, González-Cordón A, Estrach-Panella T, García-de Olalla P, Alsina-Gibert M. Moreno-Ribera N, et al. Among authors: blanco arevalo jl. Actas Dermosifiliogr. 2016 Apr;107(3):235-41. doi: 10.1016/j.ad.2015.10.007. Epub 2015 Dec 19. Actas Dermosifiliogr. 2016. PMID: 26708458 Free article. English, Spanish.
[Leprosy simulating other diseases].
López-Vélez R, Sáez Vaquero T, Blanco Arévalo JL, Gómez Mampaso E. López-Vélez R, et al. Among authors: blanco arevalo jl. Rev Clin Esp. 1999 Jun;199(6):369-72. Rev Clin Esp. 1999. PMID: 10432812 Spanish.
Dolutegravir in antiretroviral-experienced patients with raltegravir- and/or elvitegravir-resistant HIV-1: 24-week results of the phase III VIKING-3 study.
Castagna A, Maggiolo F, Penco G, Wright D, Mills A, Grossberg R, Molina JM, Chas J, Durant J, Moreno S, Doroana M, Ait-Khaled M, Huang J, Min S, Song I, Vavro C, Nichols G, Yeo JM; VIKING-3 Study Group. Castagna A, et al. J Infect Dis. 2014 Aug 1;210(3):354-62. doi: 10.1093/infdis/jiu051. Epub 2014 Jan 19. J Infect Dis. 2014. PMID: 24446523 Free PMC article. Clinical Trial.